EDESA BIOTECH, INC. Accrued Royalties, Current
EDESA BIOTECH, INC. (EDSA) had Accrued Royalties, Current of $15.00 thousand as of 2023-12-31, per its 10-Q filed 2024-02-09.
Discontinued › Notes › Payables and Accruals
us-gaap:AccruedRoyaltiesCurrent · last filed 2024-02-09
- 2023-12-31: Accrued Royalties, Current $15.00K.
- 2023-09-30: Accrued Royalties, Current $15.00K.
- 2022-12-31: Accrued Royalties, Current $0.00.
- 2022-09-30: Accrued Royalties, Current $22.00K.
| Period end | Accrued Royalties, Current |
|---|---|
| 2023-12-31 | $15.00K 10-Q · filed 2024-02-09 |
| 2023-09-30 | $15.00K 10-K · filed 2023-12-15 |
| 2022-12-31 | $0.00 10-Q · filed 2024-02-09 |
| 2022-09-30 | $22.00K 10-K · filed 2023-12-15 |
| 2020-06-30 | $23.46K 10-K · filed 2021-12-28 |
| 2020-03-31 | $23.46K 10-Q · filed 2021-05-14 |
| 2019-12-31 | $23.46K 10-Q · filed 2021-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |